Basit öğe kaydını göster

Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis

dc.contributor.authorOzkan, Zeynep Gözde
dc.contributor.authorYilmaz, Ebru
dc.contributor.authorTurkmen, Cuneyt
dc.contributor.authorSaglam, Sezer
dc.contributor.authorKaraca, Cetin
dc.contributor.authorPoyanli, Arzu
dc.contributor.authorUcar, Adem
dc.contributor.authorAkyuz, Filiz
dc.contributor.authorKeskin, Serkan
dc.contributor.authorKuyumcu, Serkan
dc.date.accessioned2021-03-04T15:02:49Z
dc.date.available2021-03-04T15:02:49Z
dc.date.issued2015
dc.identifier.citationOzkan Z. G. , Poyanli A., Ucar A., Kuyumcu S., Akyuz F., Keskin S., Saglam S., Yilmaz E., Karaca C., Turkmen C., "Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis", CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, cilt.30, sa.3, ss.132-138, 2015
dc.identifier.issn1084-9785
dc.identifier.othervv_1032021
dc.identifier.otherav_84bd3018-2a5f-4d78-b9e9-9f5ebae38b79
dc.identifier.urihttp://hdl.handle.net/20.500.12627/90278
dc.identifier.urihttps://doi.org/10.1089/cbr.2014.1748
dc.description.abstractPurpose: Although some algorithms are defined for the treatment of advanced hepatocellular carcinoma (HCC), the expected survival cannot be prolonged as it is intended. Treatment options for this group of patients are limited. Radioembolization with yttrium-90 (Y-90) microspheres is a new treatment modality, which has also been used in advanced HCC patients. In this study, the authors aimed to assess the efficiency of radioembolization with Y-90 microspheres and evaluate prognostic factors that influence the survival in HCC patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectNükleer Tıp
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.subjectTıp
dc.titleFavorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis
dc.typeMakale
dc.relation.journalCANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume30
dc.identifier.issue3
dc.identifier.startpage132
dc.identifier.endpage138
dc.contributor.firstauthorID98772


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster